Literature DB >> 7620009

Comparison of values of antibody to Bordetella pertussis antigens in young German and American men.

J D Cherry1, T Beer, S A Chartrand, J DeVille, E Beer, M A Olsen, P D Christenson, C V Moore, K Stehr.   

Abstract

Pertussis is well controlled in the United States by routine childhood immunization. In contrast, this disease is endemic and epidemic in Germany because routine immunization has not been implemented. To gain information relating to the epidemiology of Bordetella pertussis infections, we examined the prevalence and magnitude of B. pertussis agglutinins and of IgG and IgA antibodies (detected by enzyme-linked immunosorbent assay) to four B. pertussis antigens--lymphocytosis-promoting factor, filamentous hemagglutinin, pertactin, and fimbriae-2--in the sera of 119 American university students and 119 German military recruits of similar age. Geometric mean titers of agglutinins and geometric mean values for IgG antibodies to the four antigens were two- to threefold higher in sera from the American students than in sera from German recruits. In contrast, the geometric mean IgA values and the percentage of subjects with detectable IgA antibodies to the four antigens were similar in the two populations. Since IgA antibody results mainly from infection and not from immunization, our data suggest that B. pertussis infections are common among both American and German young adults despite the marked difference in rates of clinical pertussis in the two countries.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7620009     DOI: 10.1093/clinids/20.5.1271

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  7 in total

1.  Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis.

Authors:  Girish S Kirimanjeswara; Luis M Agosto; Mary J Kennett; Ottar N Bjornstad; Eric T Harvill
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

2.  Pertussis in adults with persistent cough in South Korea.

Authors:  W B Park; S W Park; H B Kim; E C Kim; M Oh; K W Choe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

Review 3.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 4.  Which strategy for pertussis vaccination today?

Authors:  Dorota Z Girard
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 5.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

6.  Serum IgA responses against pertussis proteins in infected and Dutch wP or aP vaccinated children: an additional role in pertussis diagnostics.

Authors:  Lotte H Hendrikx; Kemal Öztürk; Lia G H de Rond; Sabine C de Greeff; Elisabeth A M Sanders; Guy A M Berbers; Anne-Marie Buisman
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

7.  International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007.

Authors:  M L Tondella; G M Carlone; N Messonnier; C P Quinn; B D Meade; D L Burns; J D Cherry; N Guiso; E L Hewlett; K M Edwards; D Xing; A Giammanco; C H Wirsing von König; L Han; L Hueston; J B Robbins; M Powell; C M Mink; J T Poolman; S W Hildreth; F Lynn; A Morris
Journal:  Vaccine       Date:  2008-12-09       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.